Stelmakh Edward
Insider CIK 1887046 · OPRX Chief Finance & Strat Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| OPRX OptimizeRx Corp | F Tax w/h | 2026-08-21 | 2026-08-24 | 1,381 | $7.71 | $10.6K | 121,791 | SEC↗ |
| OPRX OptimizeRx Corp | F Tax w/h | 2026-08-21 | 2026-08-24 | 1,381 | $7.71 | $10.6K | 121,791 | SEC↗ |
| OPRX OptimizeRx Corp | F Tax w/h | 2025-12-23 | 2025-12-23 | 3,658 | $12.74 | $46.6K | 123,172 | SEC↗ |
| OPRX OptimizeRx Corp | M Exercise deriv | 2025-12-19 | 2025-12-22 | 5,237 | — | $0 | 5,237 | SEC↗ |
| OPRX OptimizeRx Corp | M Exercise deriv | 2025-12-19 | 2025-12-23 | 5,237 | — | $0 | 5,237 | SEC↗ |
| OPRX OptimizeRx Corp | M Exercise | 2025-12-19 | 2025-12-22 | 5,237 | — | $0 | 128,218 | SEC↗ |
| OPRX OptimizeRx Corp | S Sale | 2025-12-19 | 2025-12-22 | 1,388 | $13.51 | $18.8K | 126,830 | SEC↗ |
| OPRX OptimizeRx Corp | F Tax w/h | 2025-12-19 | 2025-12-23 | 1,388 | $13.51 | $18.8K | 126,830 | SEC↗ |
| OPRX OptimizeRx Corp | M Exercise | 2025-12-19 | 2025-12-23 | 5,237 | — | $0 | 128,218 | SEC↗ |
| OPRX OptimizeRx Corp | M Exercise deriv | 2025-10-03 | 2025-10-07 | 16,623 | — | $0 | 0 | SEC↗ |
| OPRX OptimizeRx Corp | F Tax w/h | 2025-10-03 | 2025-10-07 | 4,406 | $18.75 | $82.6K | 122,981 | SEC↗ |
| OPRX OptimizeRx Corp | M Exercise | 2025-10-03 | 2025-10-07 | 16,623 | — | $0 | 127,387 | SEC↗ |
| OPRX OptimizeRx Corp | A Award deriv | 2025-08-21 | 2025-08-25 | 35,156 | — | $0 | 35,156 | SEC↗ |
| OPRX OptimizeRx Corp | A Award | 2025-08-21 | 2025-08-25 | 15,625 | — | $0 | 110,764 | SEC↗ |
| OPRX OptimizeRx Corp | F Tax w/h | 2025-02-15 | 2025-02-20 | 2,156 | $6.64 | $14.3K | 95,139 | SEC↗ |
| OPRX OptimizeRx Corp | A Award deriv | 2024-12-23 | 2024-12-27 | 77,742 | — | $0 | 77,742 | SEC↗ |
| OPRX OptimizeRx Corp | A Award | 2024-12-23 | 2024-12-27 | 41,408 | — | $0 | 97,295 | SEC↗ |
| OPRX OptimizeRx Corp | M Exercise deriv | 2024-12-19 | 2024-12-20 | 5,237 | — | $0 | 10,474 | SEC↗ |
| OPRX OptimizeRx Corp | F Tax w/h | 2024-12-19 | 2024-12-20 | 1,316 | $4.75 | $6.3K | 37,287 | SEC↗ |
| OPRX OptimizeRx Corp | M Exercise | 2024-12-19 | 2024-12-20 | 5,237 | — | $0 | 38,603 | SEC↗ |
| OPRX OptimizeRx Corp | M Exercise deriv | 2024-10-11 | 2024-10-15 | 8,222 | — | $0 | 0 | SEC↗ |
| OPRX OptimizeRx Corp | F Tax w/h | 2024-10-11 | 2024-10-15 | 2,066 | $6.63 | $13.7K | 33,366 | SEC↗ |
| OPRX OptimizeRx Corp | M Exercise | 2024-10-11 | 2024-10-15 | 8,222 | — | $0 | 35,432 | SEC↗ |
| OPRX OptimizeRx Corp | M Exercise deriv | 2024-10-03 | 2024-10-07 | 16,622 | — | $0 | 16,583 | SEC↗ |
| OPRX OptimizeRx Corp | M Exercise | 2024-10-03 | 2024-10-07 | 16,622 | — | $0 | 31,387 | SEC↗ |
| OPRX OptimizeRx Corp | F Tax w/h | 2024-10-03 | 2024-10-07 | 4,177 | $7.83 | $32.7K | 27,210 | SEC↗ |
| OPRX OptimizeRx Corp | A Award | 2024-02-15 | 2024-12-27 | 0 | — | $0 | 33,365 | SEC↗ |
| OPRX OptimizeRx Corp | A Award | 2024-02-15 | 2024-04-24 | 7,083 | — | $0 | 14,765 | SEC↗ |
| OPRX OptimizeRx Corp | M Exercise | 2023-10-11 | 2024-04-22 | 8,221 | — | $0 | 28,034 | SEC↗ |
| OPRX OptimizeRx Corp | M Exercise deriv | 2023-10-11 | 2023-10-12 | 8,221 | — | $0 | 8,222 | SEC↗ |
| OPRX OptimizeRx Corp | F Tax w/h | 2023-10-11 | 2023-10-12 | 2,066 | $7.15 | $14.8K | 29,537 | SEC↗ |
| OPRX OptimizeRx Corp | M Exercise | 2023-10-11 | 2023-10-12 | 6,155 | — | $0 | 31,603 | SEC↗ |
| OPRX OptimizeRx Corp | M Exercise deriv | 2023-10-03 | 2023-10-06 | 16,662 | — | $0 | 33,205 | SEC↗ |
| OPRX OptimizeRx Corp | M Exercise | 2023-10-03 | 2023-10-06 | 16,662 | — | $0 | 21,344 | SEC↗ |
| OPRX OptimizeRx Corp | F Tax w/h | 2023-10-03 | 2023-10-06 | 4,117 | $7.06 | $29.1K | 17,227 | SEC↗ |
| OPRX OptimizeRx Corp | F Tax w/h | 2022-10-11 | 2024-04-22 | 3,539 | $15.17 | $53.7K | 7,682 | SEC↗ |
| OPRX OptimizeRx Corp | M Exercise deriv | 2022-10-11 | 2023-10-12 | 8,221 | — | $0 | 16,443 | SEC↗ |
| OPRX OptimizeRx Corp | M Exercise | 2022-10-11 | 2023-10-12 | 8,221 | — | $0 | 25,448 | SEC↗ |
| OPRX OptimizeRx Corp | M Exercise deriv | 2022-10-11 | 2023-03-30 | 8,221 | — | $0 | 16,443 | SEC↗ |
| OPRX OptimizeRx Corp | M Exercise | 2022-10-11 | 2023-03-30 | 8,221 | — | $0 | 11,221 | SEC↗ |
| OPRX OptimizeRx Corp | F Tax w/h | 2022-10-11 | 2023-03-30 | 6,539 | $15.17 | $99.2K | 4,682 | SEC↗ |
| OPRX OptimizeRx Corp | A Award deriv | 2022-10-03 | 2022-10-05 | 49,867 | — | $0 | 49,867 | SEC↗ |
| OPRX OptimizeRx Corp | A Award deriv | 2022-10-03 | 2022-10-05 | 97,637 | — | $0 | 97,637 | SEC↗ |
| OPRX OptimizeRx Corp | P Buy | 2022-08-15 | 2022-08-17 | 3,000 | $15.43 | $46.3K | 3,000 | SEC↗ |
| OPRX OptimizeRx Corp | A Award deriv | 2021-10-11 | 2021-10-13 | 24,664 | — | $0 | 24,664 | SEC↗ |
| OPRX OptimizeRx Corp | A Award deriv | 2021-10-11 | 2021-10-13 | 25,191 | — | $0 | 25,191 | SEC↗ |
| OPRX OptimizeRx Corp | A Award deriv | 2024-02-21 | 15,711 | — | $0 | 15,711 | SEC↗ | |
| OPRX OptimizeRx Corp | A Award deriv | 2024-02-21 | 15,711 | — | $0 | 15,711 | SEC↗ |